12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

BGM Galectin-3 heart failure risk test regulatory update

BG Medicine said the Centers for Medicare and Medicaid Services (CMS) assigned a payment rate for the BGM Galectin-3 heart failure risk test under an analyte-specific current procedural terminology (CPT) code, effective Jan. 1, 2013. However, CMS did not award a higher...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >